Get the Stockscreener App
1.065
1.79%
0.015
Canopy Growth Corporation stock is traded at $1.065, with a volume of 1.18M.
It is up +1.79% in the last 24 hours and down -12.39% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.05
Open:
$1.08
24h Volume:
1.18M
Relative Volume:
0.14
Market Cap:
$217.48M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.1561
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
-3.71%
1M Performance:
-12.39%
6M Performance:
-46.29%
1Y Performance:
-85.94%
1-Day Range:
$1.05
$1.0891
1-Week Range:
$1.01
$1.14
52-Week Range:
$0.77
$7.805
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.0601 | 190.63M | 211.87M | -551.61M | -140.45M | -6.8241 |
|
ZTS
Zoetis Inc
|
147.89 | 67.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 45.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.5105 | 44.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.38 | 18.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
132.87 | 13.28B | 2.41B | 305.80M | 492.20M | 2.95 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Canopy Growth names Miles Worne as European markets managing director - Investing.com
Canopy Growth names Miles Worne European markets managing director - StreetInsider
Former Curaleaf President Takes Helm of Canopy Growth's European Medical Cannabis Operations - Stock Titan
Canopy Growth Appoints Miles Worne as Managing Director of European Markets - Bluefield Daily Telegraph
Canopy Growth Agrees to Make 3 Prepayments to Reduce Term Loan by $50 Million - Cannabis Business Times
Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now? - Yahoo Finance
How To Trade (WEED) (WEED:CA) - news.stocktradersdaily.com
Canopy Growth to reduce debt by $50 million through prepayments - Investing.com India
Canopy Growth plans $50 million debt reduction through early prepayments - StreetInsider
Canopy Growth Makes Strategic $50M Early Debt Payment: What This Means for Cannabis Giant's Financial Health - Stock Titan
Canopy Growth to Strengthen Balance Sheet with Early Prepayments Set to Reduce Term Loan by US$50 Million; Annual Cash Interest Expense Expected to be Reduced by US$6.5 Million - Yahoo Finance
1 Cannabis Stock That’s My Speculative Sector Play - Yahoo.co
What institutional investors are buying Canopy Growth Corporation stockOutstanding risk-reward balance - jammulinksnews.com
Should I hold or sell Canopy Growth Corporation stock in 2025Unlock hidden market opportunities today - jammulinksnews.com
Is it the right time to buy Canopy Growth Corporation stockHigh-octane investment opportunities await - jammulinksnews.com
When is Canopy Growth Corporation stock expected to show significant growthExceptional market performance - jammulinksnews.com
Is Canopy Growth Corporation a Top Dividend Stock to Watch in 2025Risk Aware High Growth Picks - metal.it
Is Canopy Growth Corporation a growth stock or a value stockMarket-leading profit generation - jammulinksnews.com
What makes Canopy Growth Corporation stock price move sharplyLow Volatility High Yield Stocks - metal.it
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know - MSN
Canopy Growth to Announce Q1 Fiscal 2026 Financial Results - The Globe and Mail
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors - MSN
Canopy Growth to Report First Quarter Fiscal 2026 Financial Resu - GuruFocus
What drives Canopy Growth Corporation stock priceExplosive wealth accumulation - PrintWeekIndia
Canopy Growth Corporation - Baystreet.ca
Stocks In Play: Canopy Growth Corporation - Barchart.com
Canopy Growth to Report First Quarter Fiscal 2026 Financial Results on August 8, 2025 - Canopy Growth
Will Canopy Growth Corporation stock benefit from interest rate changesFree Consultation - jammulinksnews.com
What analysts say about Canopy Growth Corporation stockFast-track wealth growth - Autocar Professional
Canopy Growth Corporation (CGC) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
(WEED) Stock Trading Blueprint (WEED:CA) - news.stocktradersdaily.com
Get a backstage pass to Canopy Growth’s Smiths Falls facility during Old Home Week. Here’s what I got to experience during my sneak peek - Inside Ottawa Valley
Canopy Growth Corporation Stock Analysis and ForecastFree Wealth Management Insights - Autocar Professional
Is Canopy Growth Corporation a good long term investmentRecord-setting profit potential - jammulinksnews.com
Canopy Growth Corporation Unveils Major Product and Leadership Shifts - StocksToTrade
(WEED) Technical Pivots with Risk Controls (WEED:CA) - news.stocktradersdaily.com
Cannabis Products Market Report 2025-2029 | Canopy Growth - GlobeNewswire
Canopy Growth: Buy, Sell, or Hold in July 2025? - ca.finance.yahoo.com
Cannabis Products Market Report 2025-2029 | Canopy Growth and Aurora Cannabis are Key Players, North America Leads with the Middle East Emerging Rapidly - Yahoo Finance
Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? - MSN
(WEED) Market Performance Analysis (WEED:CA) - news.stocktradersdaily.com
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell? - yahoo.co
Canopy Growth Corporation (CGC) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
1.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):